Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00901472 · ClinicalTrials.gov registry record

Sleep Disordered Breathing and Diabetes

A clinical trial, sponsored by University of Chicago.

Completed
Registry status
105
Enrollment target

NCT00901472 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 105 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00901472 has completed, sponsored by University of Chicago.

COMPLETED
Registry status
105 participants
Enrollment target

Study Summary

The hypothesis of this study is: sleep disordered breathing (SDB), specifically, obstructive sleep apnea, is associated with poorer glucose in the existing type 2 diabetic condition. In an exploration of this hypothesis, the investigators hope to provide evidence linking SDB to increased severity of disease in the type 2 diabetic patient. By doing so, the investigators ultimately seek to support investigating the use of SDB interventions as an additional method of care in the treatment of type 2 diabetes.

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2007-02
Est. Completion 2009-12

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT00901472

The ClinicalTrials.gov registry entry for NCT00901472 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00901472 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00901472 about?

NCT00901472 is a clinical study titled "Sleep Disordered Breathing and Diabetes". The hypothesis of this study is: sleep disordered breathing (SDB), specifically, obstructive sleep apnea, is associated with poorer glucose in the existing type 2 diabetic condition. In an exploration of this hypothesis, the investigators hope to provide evidence linking SDB to increased severity o...

What is the current status of trial NCT00901472?

This trial is currently completed. The enrollment target is 105 participants. The study started on 2007-02. Estimated completion is 2009-12.

Who is sponsoring clinical trial NCT00901472?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.